The French-Belgian medtech uses a portable headset to capture up to 800 infrared images per eye per second, extracting oculomotor biomarkers that can indicate Parkinson’s, Alzheimer’s, and multiple sclerosis years before clinical symptoms appear. It received CE certification in January 2025 and is targeting FDA clearance in 2026. neuroClues, a French-Belgian medtech company developing an […]

In short: Anthropic is in negotiations to anchor a new joint venture with Blackstone, Hellman & Friedman, and Permira that would embed Claude across private equity portfolio companies, investing roughly $200m of its own capital into a vehicle that could raise up to $1bn from buyout firms, and taking Palantir’s forward-deployed engineer model as its template. […]

The AI design platform is paying creators based on engagement performance rather than audience size, marking its transition from a tool into a platform where creators can earn directly. The launch follows an AI agent marketplace the company introduced in March. Picsart has launched a creator monetisation programme open to all of its more than […]

The Iran war is not making cloud suddenly expensive. It is exposing how cloud economics was always downstream from energy markets, and Europe is structurally exposed. The current conflict in the Middle East is no longer contained to the region. Its effects are beginning to ripple into economies still recovering from the 2022 energy crisis, […]

Pershing Square’s non-binding proposal values UMG at €30.40 per share, a 78% premium to its last closing price. Ackman argues the world’s largest music label has been undervalued by structural factors, including the Bolloré Group’s 18% stake and the postponement of a US listing, that have nothing to do with its underlying business. Bill Ackman’s […]